Fujifilm (OTCMKTS:FUJIY) Shares Pass Above Two Hundred Day Moving Average - Here's What Happened

Key Points

• Fujifilm Holdings Corp. shares crossed above their 200-day moving average of $10.40 and last traded at $10.57, indicating potential market interest.
• Analysts recently downgraded Fujifilm from a "buy" to a "hold" rating, reflecting a more cautious outlook on the stock.
• The company reported earnings of $0.22 per share, surpassing analyst expectations of $0.18, with total revenue of approximately $6.06 billion for the quarter.

Fujifilm Holdings Corp. (OTCMKTS:FUJIY - Get Free Report)'s share price crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $10.40 and traded as high as $10.70. Fujifilm shares last traded at $10.57, with a volume of 145,509 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen lowered Fujifilm from a "buy" rating to a "hold" rating in a research note on Friday, May 23rd.

Fujifilm Price Performance

The firm has a 50 day simple moving average of $10.64 and a 200-day simple moving average of $10.42. The company has a quick ratio of 0.92, a current ratio of 1.40 and a debt-to-equity ratio of 0.14. The company has a market cap of $29.39 billion, a PE ratio of 10.64, a price-to-earnings-growth ratio of 3.43 and a beta of 0.67.

Fujifilm (OTCMKTS:FUJIY - Get Free Report) last posted its earnings results on Wednesday, August 6th. The technology company reported $0.15 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.15. Fujifilm had a return on equity of 7.73% and a net margin of 7.93%. The company had revenue of $5.08 billion for the quarter, compared to analyst estimates of $760.41 billion. As a group, research analysts predict that Fujifilm Holdings Corp. will post 0.66 earnings per share for the current fiscal year.

About Fujifilm

FUJIFILM Holdings Corporation develops, manufactures, sells, and services imaging, healthcare, materials, and business innovation solutions worldwide. The company's Healthcare segment provides products and services, such as medical devices, biomedical contract development and manufacturing organization, pharmaceutical, regenerative medicine, and cosmetics and supplements in the areas of prevention, diagnosis, and treatment.